H Overkleeft
01.03.2013
Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
Kraus M, Bader J, Overkleeft H, Driessen C. Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance. Blood Cancer J 2013; 3:e103.
01.03.2013Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
01.03.2013Blood Cancer J 2013; 3:e103
Kraus Marianne, Bader J, Overkleeft H, Driessen Christoph
Weiter
01.01.2007
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
Kraus M, Ovaa H, Overkleeft H, Burg D, Berkers C, Kammer W, Beck A, Gogel J, Reich M, Rückrich T, Driessen C. Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007; 21:84-92.
01.01.2007Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
01.01.2007Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007; 21:84-92
Kraus Marianne, Ovaa H, Overkleeft H, Burg D, Berkers C R, Kammer W, Beck A, Gogel J, Reich M, Rückrich T, Driessen Christoph
Weiter